Sasunova A N, Goncharov A A, Morozov S V, Isakov V A
Federal Research Center for Nutrition, Biotechnology and Food Safety.
Ter Arkh. 2022 Oct 12;94(8):973-978. doi: 10.26442/00403660.2022.08.201773.
To assess efficacy of dietary patterns modification with the use of specialized food in patients with non-alcoholic steatohepatitis (NASH).
We developed new specialized food (SPP2) based on literature data on the role of dietary patterns in pathogenesis of NASH. It contained -3 PUFAs, soluble dietary fiber, phospholipids, -lipoic acid, coenzyme Q10, L-carnitine, complex of vitamins. Patients with NASH (per EASL guidelines), were invited to participate in the study and were randomly assigned to receive either isocaloric diet (ICD) alone (based on the results of indirect calorimetry Cosmed, Italy) or isocaloric diet with specialized food (2 portions of SPP2 a day), for 14 days. Repeated examinations of body composition with phase angle analysis (InBody, Republic of Korea) and blood chemistry were performed at baseline (BL) and after 14 days (EOT). The patients were advised to follow usual physical activity during the study. Non-parametric statistics was used to compare BL and EOT characteristics in the groups.
The groups did not differ by age, proportion of females, and baseline characteristics of body composition. Adherence to the diet was 87.5% in the ICD group and 88.2% in the ICD+SPP group (p=0.65). Compliance with the use of SPP was 100%. In the ICD+SPP group significant reduction of body weight was achieved (117.530.1 kg initially, vs 114.928.8 kg at EOT; p=0.007), whereas in the ICD group it was not statistically significant (106.722.1 kg at BL vs 104.016.8 kg at EOT, respectively; p=0.07). In contrast to the ICD group, in those who received ICD+SPP significant decrease in cholesterol (5.31.3 mmol/L at BL vs 4.61.3 mmol/L at EOT; p=0.003), LDL (3.71.0 mmol/L vs 3.31.0 mmol/L, respectively; p=0.009), alkaline phosphatase (132.699.1 vs 112.087.0 U/L; p=0.04), GGT (54.533.2 vs 37.519.7 U/L; p=0.04), insulin resistance index (6.13.2 vs 3.21.5, respectively; p=0.04) was detected.
Modification of dietary patterns with the use of a specialized food in combination with low-calorie diet allows achieving significant reduction of weight and improve lipid and carbohydrate metabolism, reduce severity of cholestasis in patients with NASH.
评估使用特殊食品改变饮食模式对非酒精性脂肪性肝炎(NASH)患者的疗效。
基于饮食模式在NASH发病机制中作用的文献数据,我们研发了新型特殊食品(SPP2)。它含有ω-3多不饱和脂肪酸、可溶性膳食纤维、磷脂、α-硫辛酸、辅酶Q10、左旋肉碱、维生素复合物。邀请符合欧洲肝脏研究学会(EASL)指南的NASH患者参与研究,并随机分配为仅接受等热量饮食(ICD)(基于意大利Cosmed间接测热法结果)或接受等热量饮食加特殊食品(每天2份SPP2),为期14天。在基线(BL)和14天后(EOT),使用相位角分析(韩国InBody)对身体成分进行重复检查,并进行血液生化检查。建议患者在研究期间保持平常的身体活动。采用非参数统计方法比较两组的BL和EOT特征。
两组在年龄、女性比例和身体成分的基线特征方面无差异。ICD组的饮食依从性为87.5%,ICD + SPP组为88.2%(p = 0.65)。SPP的使用依从性为100%。ICD + SPP组体重显著减轻(初始体重为117.±3.1 kgvs EOT时为114.9±2.88 kg;p = 0.007),而ICD组无统计学意义(BL时为106.7±2.21 kg,EOT时为104.0±1.68 kg,分别为;p = 0.07)。与ICD组相比,接受ICD + SPP的患者胆固醇显著降低(BL时为5.3±1.3 mmol/L,EOT时为4.6±1.3 mmol/L;p = 0.003),低密度脂蛋白(分别为3.7±1.0 mmol/L和3.3±1.0 mmol/L;p = 0.009),碱性磷酸酶(132.6±99.1 vs I12.0±87.0 U/L;p = 0.04),γ-谷氨酰转肽酶(GGT)(54.5±33.2 vs 37.5±19.7 U/L;p = 0.04),胰岛素抵抗指数(分别为6.1±3.2和3.2±1.5;p = 0.04)。
使用特殊食品结合低热量饮食改变饮食模式可使NASH患者体重显著减轻,改善脂质和碳水化合物代谢,降低胆汁淤积的严重程度。